medigraphic.com
Academia Mexicana de Neurología, A.C.

2011, Number 5

<< Back Next >>

Rev Mex Neuroci 2011; 12 (5)

Cerebrovascular disease mortality in Mexico, 2000–2008: A call for action

Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Villarreal-Careaga J, Barinagarrementería F, Cantú-Brito C

Language: Spanish
References: 30
Page: 235-241
PDF size: 252.48 Kb.


ABSTRACT

Introduction: Cerebrovascular disease (CVD) is a growing health problem in countries living the epidemiological transition. In Mexico, population data on this issue is scarce. Objective: To describe the changing pattern on CVD mortality in Mexico, during the period 2000 to 2008. Methods: We consulted the Mexican Health Ministry database provided by the National System on Health Information. Data on the period 2000 to 2008 (the only available) was extracted. Crude CVD deaths, annualized population mortality rates and proportions attributed to CVD among other mortality causes are here presented. Results: By the year 2000 a total of 435,486 deaths were registered in Mexico (general mortality rate: 4.42/100,000; total population: 98,438,557 inhabitants), increasing to 538,288 in 2008 (general mortality rate: 5.05/100,000; total population: 106,682,518 inhabitants), which coincided with an increment in the population aged ≥ 65 years specifically (year 2000: 4,591,319; year 2008: 5,983,927). Specific CVD mortality also showed a growing pattern from 2000 (annualized mortality rate: 25.21/100,000) to 2008 (annualized mortality rate: 28.30/100,000). By 2008, the Mexican state with the highestCVD mortality rate was Veracruz (annualized mortality rate: 36.3/100,000), followed by Oaxaca (annualized mortality rate: 36.2/100,000) and the Federal District (annualized mortality rate: 34.9/100,000). Of note, a decreasing annualized mortality rate was observed in the population aged ≥ 65 years, at expense of a higher frequency at younger ages. Conclusions: CVD mortality has increased in Mexico, particularly in persons aged ‹ 65 years. Comprehensive population studies on fatal and non-fatal CVD incidence by specific clinical types are urgently needed.


REFERENCES

  1. Lavados PM, Hennis AJM, Fernandes JG, Medina MT, Legetic B, Hoppe A, et al. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol 2007; 6: 362-72.

  2. Barquera S, Tovar-Guzmán V, Campos-Nonato I, González-Villalpando C, Rivera-Dommarco J. Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Arch Med Res 2003; 34: 407-14.

  3. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009; 8: 345-54.

  4. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 populationbased studies: A systematic review. Lancet Neurol 2009; 8: 355-69.

  5. Röther J, Alberts MJ, Touzé E, Mas JL, Hill MD, Michel P, et al. Risk factor profile and management of cerebrovascular patients in the REACH registry. Cerebrovasc 2008; 25: 366-74.

  6. Grau AJ, Weimar Ch, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke. The German Stroke Data Bank. Stroke 2001; 32: 2559-66.

  7. Ruiz-Sandoval JL, León-Jiménez C, Chiquete-Anaya E, Sosa-Hernández JL, Espinosa-Casillas CA, Cantú C, et al. Estilos de vida y prevención primaria y secundaria de enfermedad vascular cerebral. Rev Invest Clin 2010; 62: 181–91.

  8. Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez-Gilabert C, Durazo-Arvizú R, Aguilar-Salinas CA. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S63-S71.

  9. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, Rebollar R, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex 2010; 52: S19-S26.

  10. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo- Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009; 51: S595-S603.

  11. Aguilar-Salinas CA, Gómez-Pérez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S44-S53.

  12. Villalpando S, Rodrigo JR. The status of non-transmissible chronic disease in Mexico based on the National Health and Nutrition Survey 2006. Introduction. Salud Publica Mex 2010; 52(Suppl. 1): S2-S3.

  13. Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Publica Mex 2010; 52: S72-9.

  14. Gómez-Pérez FJ, Rojas R, Villalpando S, Barquera S, Rull J, Aguilar- Salinas CA. Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system. Salud Publica Mex 2010; 52: S54-S62.

  15. Jiménez-Corona A, Rojas R, Gómez-Pérez FJ, Aguilar-Salinas CA. Earlyonset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S27- S35.

  16. Arauz A, Cantú C, Ruiz-Sandoval JL, Villarreal-Careaga J, Barinagarrementeria F, Murillo-Bonilla L, Fernández JA, et al. Pronóstico a corto plazo de la isquemia cerebral transitoria. Registro multicéntrico de enfermedad vascular cerebral en México. Rev Inv Clin 2006; 58: 530-9.

  17. Ruiz-Sandoval JL, Cantú C, Chiquete E, León-Jiménez C, Arauz A, Murillo-Bonilla LM, et al. Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC registry. J Stroke Cerebrovasc Dis 2009; 18: 48-55.

  18. Ruiz-Sandoval JL, Ortega-Alvarez L, García-Navarro V, Romero-Vargas S, González-Cornejo S. Hemorragia intracerebral en un hospital de referencia de la región centro-occidente de México. Rev Neurol 2005; 40: 656-60.

  19. Ruiz-Sandoval JL, Chiquete E, Bañuelos-Becerra LJ, Torres-Anguiano C, González-Padilla C, Arauz A, León-Jiménez C, Murillo-Bonilla LM, et al. Cerebral Venous Thrombosis in a Mexican Multicenter Registry of Acute Cerebrovascular Disease: The RENAMEVASC Study. J Stroke Cerebrovasc Dis. [Epub ahead of print].

  20. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León- Jiménez C, Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos- Moreno A; PREMIER Investigators. The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demographics, risk factors and outcome. Int J Stroke 2011; 6: 93–4.

  21. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León- Jiménez C, Arauz A, Villarreal-Careaga J, et al. Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010; 51: 641-9.

  22. Leon-Jimenez C, Chiquete E, Cantu C, Miramontes-Saldana MJ, Andrade- Ramos MA, Ruiz-Sandoval JL. Citicoline for acute ischemic stroke in Mexican hospitals: a retrospective postmarketing analysis. Methods Find Exp Clin Pharmacol 2010; 32: 325-30.

  23. Ochoa GA, Chiquete E, Cantú-Brito C, Arauz A, Murillo-Bonilla L, Villarreal-Careaga J, et al. Lupus eritematoso generalizado en un registro hospitalario multicéntrico de enfermedad cerebrovascular aguda en México: Estudio RENAMEVASC. Rev Mex Neuroci 2010; 11: 463-9.

  24. Cantú-Brito C, Ruiz-Sandoval JL, Arauz-Góngora A, Villarreal-Careaga J, Barinagarrementería F, Murillo-Bonilla LM, Chiquete E, Rangel-Guerra R. Prevalencia de estenosis carotídea en pacientes con isquemia cerebral transitoria en México. Rev Mex Neuroci 2010; 11: 343-8.

  25. Murillo-Bonilla LM, Lizola-Hernández J, Lepe-Cameros L, Ruiz-Sandoval JL, Chiquete E, León-jiménez C, et al. Factores predictivos de discapacidad funcional y muerte a 30 días en sujetos con infarto cerebral agudo: Resultados del Registro Nacionla Mexicano de Enfermedad Vascular Cerebral (estudio RENAMEVASC). Rev Mex Neuroci 2011; 12: 68–75.

  26. Cantu-Brito C, Majersik JJ, Sánchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB. Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain Attack Surveillance in Durango Study. Stroke 2011; 42: 601-6.

  27. Cantu-Brito C, Majersik JJ, Sánchez BN, Ruano A, Quiñones G, Arzola J, Morgenstern LB. Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance in Durango study. Stroke 2010; 41: 878-84.

  28. Estadísticas sobre mortalidad general. SINAIS, Mexico, 2008. Consultado en agosto 01, 2011. (http://sinais.salud.gob.mx/).

  29. Estadísticas sobre actividad económica en las entidades federativas. INEGI, México, 2010. Consultado en agosto 01, 2011. (http://www.inegi.org.mx/).

  30. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol 2004; 3: 391-3.




2020     |     www.medigraphic.com